Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 46 (RPL31P46) is a processed pseudogene located on chromosome 11 (GRCh38:CM000673.2), specifically at 74,919,587-74,919,965 on the forward strand[2]. It is a genomic fragment derived from the functional RPL31 gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis[7][3]. Pseudogenes like RPL31P46 are typically non-functional, result from retrotransposition events, and are distributed throughout the human genome[5]. While ribosomal protein pseudogenes may act as evolutionary markers or—much more rarely—have regulatory effects, RPL31P46 does not encode a functional protein and has no recognized biological or disease role[2][5][8].\n\nIn summary, RPL31P46 (Ribosomal protein L31 pseudogene 46) is a non-functional pseudogene and not a therapeutic target, receptor, enzyme, transporter, nor used in drug discovery or clinical biomarker applications[2][5][8].
None; pseudogenes do not encode protein, thus no drug mechanism is applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 46 (RPL31P46).